Table 3.
Echocardiographic abnormalities according to pre-existing comorbidities
| Echocardiographic finding | Non comorbidities (61.7%; n = 367) | With comorbidities (38.3%; n = 228) | “p” |
|---|---|---|---|
| Mid-range LVEF | 2.7% (10) | 3.6% (8) | 0.572 |
| LVEF below 40% | 0.3% (1) | 1.4% (3) | 0.128 |
| Abnormal wall motions in LV | 1.1% (4) | 8.8% (20) | < 0.001 |
| Reduced GLS (below −18.0%) | 5.7% (21) | 21.1% (48) | < 0.001 |
| Dilated RV | 1.6% (6) | 2.2% (5) | 0.630 |
| Reduced RV function | 0.27% (1) | 1.8% (4) | 0.074 |
| Reduced RV GLS (n = 460)* | 3.1% (9) | 7.2% (12) | 0.060 |
| Pericardial effusion | 0.82% (3) | 1.8% (4) | 0.437 |
| PASP (n = 329) | 27.3 ± 4.5 mmHg | 29.0 ± 5.9 mmHg | 0.003 |
*For RV a reduced GLS was considered with a value under − 20.0%
LVEF left ventricular ejection fraction, GLS global longitudinal strain, RV right ventricle, PASP Pulmonary artery systolic pressure